首页 正文

CDK 4/6 inhibitor induced lung injury: a case report and review of literature

{{output}}
Palbociclib is a cyclin dependent kinase (CDK) 4/6 inhibitor that is indicated in combination with an aromatase inhibitor for first-line treatment of hormone receptor-positive, human epidermal growth factor receptor 2 -negative advanced or metastatic breast ca... ...